Treatment of Diabetic Complications. Strict Glycemic Control and Diabetic Microvascular Complications.
نویسندگان
چکیده
منابع مشابه
Glycemic control and the risk of multiple microvascular diabetic complications.
BACKGROUND AND OBJECTIVES Tight glycemic control in type 2 diabetes reduces risk of certain end-organ complications. However, among patients with one complication already, it is unknown whether tight glycemic control reduces the risk of subsequent complications in another organ. We sought to determine if glycemic control is associated with the risk of a second, distinct, end-organ diabetic comp...
متن کاملGlycemic Control, Complications, and Death in Older Diabetic Patients
OBJECTIVE To identify the range of glycemic levels associated with the lowest rates of complications and mortality in older diabetic patients. RESEARCH DESIGN AND METHODS We conducted a retrospective cohort study (2004-2008) of 71,092 patients with type 2 diabetes, aged ≥60 years, enrolled in Kaiser Permanente Northern California. We specified Cox proportional hazards models to evaluate the r...
متن کاملPKC inhibition and diabetic microvascular complications.
In patients with diabetes, the hyperglycaemia is known to promote high levels of diacylglycerol which activates protein kinase C (PKC) in the vascular tissues and leads to production of vascular endothelial growth factor (VEGF) in the retina. PKC activation is likely to play a key role in diabetic microvascular complications, particularly changes in vascular permeability and ischaemia in the re...
متن کاملInflammation and diabetic retinal microvascular complications
Diabetic retinopathy (DR) is one of the most common complications of diabetes and is a leading cause of blindness in people of the working age in Western countries. A major pathology of DR is microvascular complications such as non-perfused vessels, microaneurysms, dot/blot hemorrhages, cotton-wool spots, venous beading, vascular loops, vascular leakage and neovascularization. Multiple mechanis...
متن کاملMicrovascular Complications in Diabetic Erectile Dysfunction
Advances in the management of erectile dysfunction (ED) and its adverse effects on the quality of life of men and their partners have encouraged researchers to look for new solutions for treating and curing ED. The introduction of phosphodiesterase type 5 inhibitors to treat ED in 1998 was revolutionary in that it heralded the onset of a new era of effective and safe treatment for restoring mal...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Internal Medicine
سال: 1997
ISSN: 0918-2918,1349-7235
DOI: 10.2169/internalmedicine.36.144